Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2012
09/12/2012CN102659850A Tetradentate Schiff base metal complex, metal porphyrin complex and method for preparing polycarbonate
09/12/2012CN102659815A Method for preparing selective anticoagulant ticagrelor and intermediates thereof
09/12/2012CN102659793A Phthalocyanine silicon modified by amino ethyl groups and phenoxy groups as well as preparation method and application thereof
09/12/2012CN102659792A Method for extracting chlorophyll from clovers
09/12/2012CN102659791A Method for extracting hemin and globin from animal blood
09/12/2012CN102659790A Organic luminescent material and preparation method and application thereof
09/12/2012CN102659789A Method preparing temozolomide in one-pot mode and refining method of temozolomide
09/12/2012CN102659788A Method for extracting nazlinin from nitraria schoberi
09/12/2012CN102659787A Fluoro polyhydroxy pyrrole pyrrolizidine, and preparation method and application thereof
09/12/2012CN102659786A 6a,7-dihydro-m-diaza naphthalene [1,2-a]-quinazoline-5,8(6H)-diketone and preparation method thereof
09/12/2012CN101817823B Preparation method of 4,7-diazaindole and 5-site substitute thereof
09/12/2012CN101575340B Preparation method of ketorolac tromethamine
09/12/2012CN101569627B Folic acid acceptor mediated molecular targeted photosensitizer and preparation method thereof
09/11/2012US8263767 AZA-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
09/11/2012US8263765 Pyrrolotriazine kinase inhibitors
09/11/2012US8263615 Bis-heterocyclic imidazolyl compounds
09/11/2012US8263612 Propylaxic or therapy of viral infections; using pyrrolo( 2,3-c)pyridine
09/11/2012US8263596 Kinase inhibitors and method of treating cancer
09/11/2012US8263557 Method and mixture for in vivo photochemical cross-linking of collagen
09/11/2012US8263094 Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
09/11/2012US8262949 Long wavelength shifted benzotriazole uv-absorbers and their use
09/11/2012CA2551640C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
09/11/2012CA2543351C Amide derivatives
09/07/2012WO2012118945A2 Fused bicyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
09/07/2012WO2012117048A1 Pharmaceutically active disubstituted triazine derivatives
09/07/2012WO2012117027A1 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
09/07/2012WO2012077932A3 Novel pyrazole pyridine derivative or pharmaceutically acceptable salts thereof, method for producing same, and pharmaceutical composition including same
09/07/2012WO2012067415A3 Compound and organic electronic device using same, and terminal comprising the organic electronic device
09/07/2012WO2011117145A3 Pyrrolopyrazine kinase inhibitors
09/07/2012CA2826464A1 Pharmaceutically active disubstituted triazine derivatives
09/07/2012CA2824360A1 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
09/06/2012US20120226217 Photosensitizing compositions
09/06/2012US20120226037 Pyrrolo [2,3-d] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
09/06/2012US20120225922 Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
09/06/2012US20120225888 Inhibitors of Human Immunodeficiency Virus Replication
09/06/2012US20120225884 Bridged piperidine derivatives
09/06/2012US20120225869 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/06/2012US20120225867 Androgen receptor modulating compounds
09/06/2012US20120225854 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
09/06/2012US20120225846 Heterocyclic compounds for the inhibition of pask
09/06/2012US20120225844 Bicyclic triazole and pyrazole lactams as allosteric modulators of mglur5 receptors
09/05/2012EP2495246A1 Fullerene derivative
09/05/2012EP2495016A1 Bicyclic Heteroaryl Compounds
09/05/2012EP2494975A1 Compounds and methods for promoting smoking cessation
09/05/2012EP2493897A1 Hydroxy-substituted gold(iii) porphyrin complexes as histone deacetylase inhibitors
09/05/2012EP2493890A1 Nitrogen-containing aromatic compounds and metal complexes
09/05/2012EP2493889A1 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
09/05/2012EP2493888A1 Bicyclic pyridines and analogs as sirtuin modulators
09/05/2012EP2493887A1 Deuterated compounds for electronic applications
09/05/2012EP2493876A1 Imidazole derivatives as casein kinase inhibitors
09/05/2012EP2493871A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
09/05/2012EP2493469A2 Pharmaceutical composition comprising indole compound
09/05/2012CN102656174A Compounds for the treatment of hepatitis C
09/05/2012CN102656173A Inhibitors of Bruton's tyrosine kinase
09/05/2012CN102656164A Pyrimidine compounds as tuberculosis inhibitors
09/05/2012CN102653541A Porphyrin compound as well as preparation method and application of porphyrin compound
09/05/2012CN102653540A New synthesis process of new antineoplastic drug INK128
09/05/2012CN102653539A Compound for resisting platelet aggregation and medicament combination thereof
09/05/2012CN101830904B Preparation method of 4-chloropyrrolo[2,3-d]pyrimidine
09/05/2012CN101730698B Compounds for the treatment of hepatitis c
09/05/2012CN101648953B Imidazo (1,2-b) pyrrolo (1,2-f) pyridazine derivative as well as preparation method and application thereof
09/05/2012CN101624394B Preparation method of sphericized hexanitrohexaazaisowurtzitane (HNIW) crystal
09/05/2012CN101563319B Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
09/05/2012CN101528688B Process for preparing indol- 5 -oxy- quinazoline derivatives and intermediates
09/05/2012CN101410400B Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
09/05/2012CN101374843B Triazolopyridazines as tyrosine kinase modulators
09/05/2012CN101248080B Inhibitors of VEGF receptor and HGF receptor signaling
09/05/2012CN101098872B Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
09/05/2012CN101068815B Lactam compounds useful as protein kinase inhibitors
09/05/2012CN101031570B Inhibitors of VEGF receptor and HGF receptor signaling
09/04/2012US8258313 Compound having hydantoin ring and method of producing the same
09/04/2012US8258294 Process for the preparation of temozolomide and analogs
09/04/2012US8258292 Methods of making dyes
09/04/2012US8258176 Dithiolopyrrolone compounds, the preparation and the use thereof
09/04/2012US8258172 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
09/04/2012US8258144 Inhibitors of protein kinases
09/04/2012US8258143 Methods of using substituted pyrrolo[2,3-d]pyrimidines for targeting tumor cells and treating cancer
09/04/2012US8258129 4-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicaments
09/04/2012US8257838 Organic electroluminescent device and platinum compound
09/04/2012CA2656578C Tyrosine kinase inhibitors
08/2012
08/30/2012WO2012116080A1 Preparation of bicyclic guanidine salts in an aqueous media
08/30/2012WO2012115575A1 Derivatives for inducing osteogenic differentiation
08/30/2012WO2012115286A1 Alpha helix mimetics and methods relating thereto
08/30/2012WO2012114928A1 Compounds having indolocarbazole ring structure, and organic electroluminescent elements
08/30/2012WO2012114252A1 Novel indole and pyrrolopyridine amides
08/30/2012WO2012114222A1 IMIDAZO[5,1-f][1,2,4]TRIAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
08/30/2012WO2012094615A3 Use of cav3.1 selective t-type calcium channel antagonists
08/30/2012US20120220770 Preparation of bicyclic guanidine salts in an aqueous media
08/30/2012US20120220769 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
08/30/2012US20120220766 TETRAHYDRO-IMIDAZO[1,5-alpha] PYRAZINE DERIVATIVES, PREPERATION PROCESS AND MEDICINAL USE THEREOF
08/30/2012US20120220599 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
08/30/2012US20120220596 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
08/30/2012US20120220595 Deuterated Tyrosine Kinase Inhibitors
08/30/2012US20120220587 Pyridinylimidazolone derivatives for the inhibition of pi3 kinases
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120220582 Imidazopyrazine syk inhibitors
08/30/2012US20120220581 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
08/30/2012US20120220576 Novel Heterocyclic Derivatives
08/30/2012US20120220573 Benzodiazepine Bromodomain Inhibitor
08/30/2012US20120220572 Tricyclic inhibitors of kinases
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 573